Research Application
The Duchenne Parent Project Netherlands (DPP NL) promotes research into improved therapies and care for Duchenne Muscular Dystrophy patients. DPP NL sponsors promising research projects and fellowships, fast exchange of data and stimulates international collaboration. Researchers from all countries are invited to submit a research project to DPP NL.
Duchenne Parent Project NL has invested over 20 million euro in research towards viable treatments for Duchenne Muscular Dystrophy over the last 20 years.
The 2025 Research Incentive Grant Call is now closed
The selected projects can be found here.
Please keep an eye on this page for updates about the 2026 call.
About Duchenne Parent Project’s funding
Duchenne Parent Project (DPP) has a multi-track policy and funds the widest possible range of Duchenne research. This includes basic research, rehabilitation research, quality of life, psychosocial research, and genetic research. We sponsor promising and innovative research projects and fellowships, facilitate the fast exchange of data, and stimulate international collaboration.
Our mission is to improve the lives of everyone affected by Duchenne Muscular Dystrophy, now and in the future. We believe that research into all aspects of DMD is essential to developing treatments that slow or stop muscle degeneration, improving care, and promoting participation in society. We are committed to ensure that every person with DMD can live a better, longer life through research, medical advancements, assistive technologies, and strong support systems.
The vision of DPP is to drive research, improve knowledge, increase awareness, and empower Duchenne families to take an active role in shaping their future. By working together with global experts and research institutions, we can accelerate solutions and create meaningful change.
Funded research projects should comply with the Grant Agreement. The conditions presented in the Agreement will not be changed.
Funded projects will be monitored closely, and grant recipients are required to submit a progress report (9 months after the start of the project) and a final report. Based on the progress report, Duchenne Parent Project, with advice from the Scientific Advisory Board, will decide on the continuation of the grant.
If pilot data is generated in this incentive grant, the researchers should aim to make the data findable, accessible, interoperable, and reusable (FAIR). If pilot data is available, we encourage these results to be published as soon as possible in a peer-reviewed open-access scientific journal, as well as in the case of ‘negative’ results.
For any inquiries regarding the call, please contact Minou Verhaeg at research@duchenne.nl.
Fast track application
We give you the opportunity to apply for smaller projects through the fast track procedure. This includes applications for workshops as well. For grant conditions, click here. The maximum budget is € 25.000.
Dr Imelda de Groot Award
The ‘Dr Imelda de Groot’ is an annual award and meant to stimulate persons to improve care for persons with Duchenne muscular dystrophy (DMD). Especially innovative projects are of interest. This award is an initiative of the foundation Duchenne Parent Project, The Netherlands.
Every professional involved in the care of persons with DMD can apply for the award. Support of the patients’ organization is advisable for the application.
Dr Imelda de Groot retired in April 2021 as a pediatric rehabilitation specialist at the Radboud University Medical Center. During her career she initiated innovative and relevant research projects in the field of Duchenne and Becker Muscular Dystrophy, such as ‘No use is disuse’ about exercise and physical activities, outcome measures and many other subjects. The goal of the award is to stimulate researchers and clinicians to develop activities in this field. Candidates for this award can be nominated by Duchenne (and Becker) patient organizations around to globe. The winner of the award, selected by a jury existing of experts including patients, will receive € 10.000 to be spend on this type of research.
